Esplugues De Llobregat

• A pharmacokinetics and safety study of cefiderocol in hospitalized pediatric patients from birth to less than 3 months of age with suspected … Not authorised
  2023-503757-35-00 4 Aerobic Gram-negative bacterial infections
• A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours Not authorised
  2023-504246-64-00 9 Relapsed/refractory neuroblastoma and other solid tumours
• A Study to Learn About the Safety, Tolerability and Blood Levels of a Study Medicine (called sisunatovir) in Infants and Children with RSV L … Not authorised
  2023-504425-39-00 3 Respiratory Syncytial Virus (RSV) Infection
• A Phase 1/2 Clinical Study of Intravenous Gene Transfer with an AAVrh10 Vector Expressing GALC in Krabbe Subjects Receiving Hematopoietic St … Not authorised
  2023-504900-28-00 7 Krabbe Disease
• Investigating a New Treatment: Clinical Study on Coenzyme Q (Ubiquinol) for Patients with Mitochondrial Disorders and Cerebellar Ataxias Not authorised
  2023-505244-18-01 4 Mitochondrial disorders and/or cerebellar ataxias
• A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluat … Pending
  2022-502365-26-00 5 Asthma
• A study to investigate efficacy and safety with pegtibatinase compared to placebo in participants ≥12 to ≤65 years of age with classical hom … Pending
  2023-504135-40-00 5 Classical Homocystinuria
• Gene Therapy Trial for OTOF-mediated Hearing Loss Pending
  2023-505128-76-00 7 Otoferlin gene-mediated hearing loss
• A Study to Learn About the Study Medicine Called Aztreonam-Avibactam in Neonates and Infants Less Than 9 Months of Age With Suspected or Con … Pending
  2023-507757-15-01 4 Sepsis
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 11 Obesity and T2D
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• Phase II Randomized Clinical Trial of quinacrine versus metronidazole in resistant giardiasis in children: Quin4Kids Pending
  2023-510227-30-00 9 Intestinal giardiasis
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 10 Medulloblastoma
• Early phase clinical trial to evaluate the safety of the combination of immunotherapy with dendritic cells pulsed and tumor lysate, together … Pending
  2024-514052-32-00 1 Patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
• A 52 week study in which neither Sponsor or participant know the treatment assigned to subjects to compare the experimental drug (CHF 5993) … Pending
  2024-514248-95-00 5 Uncontrolled Asthma
• A Long-Term Extension Study to Evaluate the Safety and Efficacy of Ritlecitinib in Participants With Severe AA Who Have Completed Studies B7 … Pending
  2024-515439-31-00 5 Alopecia areata
• Study of hydroxocobalamin at a new concentration for cobalamin-related remethylation disorders. Pending
  2024-516862-12-00 10 Hydroxycobalamin deficiency
• A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute M … Pending
  2024-520125-36-00 3 Relapsed or Refractory Acute Myeloid Leukemia; Acute Myeloid Leukemia
• A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf … Pending
  2025-521230-29-00 5 Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Der
• A study of Mirdametinib in Infants and Toddlers under 24months of age with Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas … Pending
  2025-522000-24-00 3 Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
• Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL Pending
  2025-522019-40-00 9 relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+)
• Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia. Pending
  2025-522138-29-00 4 Philadelphia positive Chronic Myeloid leukemia in Chronic Phase with n
• A clinical trial of ifinatamab deruxtecan in people under age 18 who have certain types of cancer (MK-9999-01D) Pending
  2025-522339-32-00 9 Neoplasm malignant
• An Open label, Single Arm, Single dose Study in Pediatric Participants aged ≥2 to <12 years with a Suspected or Confirmed Bacterial Infecti … Pending
  2025-522916-17-00 3 Urinary Tract Infections

Showing 1–24 of 317 trials